Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on Therapy

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES(2024)

引用 0|浏览0
暂无评分
摘要
The objective of this two-part review is to present a current and comprehensive understanding of the diagnosis and management of plasmablastic lymphoma. The first part, which was published previously, focused on the study of epidemiology, etiology, clinicopathological characteristics, differential diagnosis, prognostic variables, and the impact of plasmablastic lymphoma on specific populations. This second part addresses the difficult topic of the treatment of plasmablastic lymphoma, specifically examining both the conventional, consolidated approach and the novel therapeutic strategy.
更多
查看译文
关键词
Aggressive Lymphoma,People living with HIV,Plasmablastic Lymphoma,CD20-negative large B-cell Lymphoma,CD38+,CD138+,V-EPOCH,Daratumumab,Lenalidomide,Bortezomib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要